Education
About Us
Working with TipRanks
Follow Us
NUMG - ETF AI Analysis
Top Page
Nuveen ESG Mid-Cap Growth ETF (NUMG)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Idexx Laboratories and Carvana, have delivered strong year-to-date gains, supporting overall performance.
Sector Diversification
The fund is spread across multiple sectors, including Technology, Industrials, and Health Care, reducing reliance on any single industry.
Reasonable Expense Ratio
The ETF's expense ratio is relatively low, making it cost-effective compared to many actively managed funds.
Negative Factors
High U.S. Concentration
With nearly all assets invested in U.S. companies, the fund lacks exposure to international markets, limiting geographic diversification.
Underperforming Holdings
Some top holdings, such as Fair Isaac and WW Grainger, have lagged in performance, which could weigh on the fund's returns.
Heavy Technology Exposure
The fund's largest sector allocation is Technology, which could make it vulnerable to downturns in this industry.
NUMG vs. SPDR S&P 500 ETF (SPY)
AUM402.90M
RegionNorth America
Expense Ratio0.31%
Beta1.14
IssuerNuveen
Inception DateDec 13, 2016
Dividend Yield0.01%
Asset ClassEquity
Index TrackedMSCI Nuveen ESG USA Mid Cap Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume45,134
30 Day Avg. Volume24,671
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
57.94Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering41
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NUMG Summary
The Nuveen ESG Mid-Cap Growth ETF (NUMG) is an investment fund that focuses on mid-sized companies with strong growth potential while ensuring they meet high environmental, social, and governance (ESG) standards. It tracks the MSCI Nuveen ESG USA Mid Cap Growth Index and includes companies like Quanta Services and Idexx Laboratories. Investors might consider NUMG for its combination of growth opportunities and ethical investing principles, making it a good option for diversification with a focus on sustainability. However, since it emphasizes mid-cap stocks, its performance can be more volatile than large-cap-focused funds.
How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.
What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.
NUMG Top 10 Holdings
The Nuveen ESG Mid-Cap Growth ETF (NUMG) leans heavily into technology, industrials, and healthcare, with standout performances from MongoDB and Ciena driving the fund’s momentum. MongoDB’s strategic focus on AI and Ciena’s bullish earnings growth have been bright spots, while lagging names like Alnylam Pharma and Verisk Analytics have weighed on returns with bearish sentiment and valuation concerns. With a U.S.-centric portfolio and a clear tilt toward innovation-driven sectors, NUMG offers a growth-oriented approach, though some holdings show mixed signals that could temper its overall trajectory.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Carvana Co | 4.68% | $19.01M | $96.06B | 97.08% | 66 Neutral | |
| Idexx Laboratories | 4.06% | $16.48M | $54.95B | 64.99% | 78 Outperform | |
| Alnylam Pharma | 3.83% | $15.54M | $52.94B | 65.23% | 60 Neutral | |
| WW Grainger | 3.79% | $15.39M | $49.01B | -4.79% | 73 Outperform | |
| Axon Enterprise | 3.58% | $14.54M | $46.65B | -5.23% | 58 Neutral | |
| Fair Isaac | 3.37% | $13.68M | $41.04B | -16.08% | 69 Neutral | |
| MongoDB | 3.32% | $13.49M | $35.45B | 78.85% | 75 Outperform | |
| Ciena | 3.19% | $12.94M | $33.84B | 171.69% | 70 Outperform | |
| Comfort Systems | 2.98% | $12.10M | $33.79B | 118.31% | 80 Outperform | |
| Verisk Analytics | 2.87% | $11.64M | $30.50B | -21.38% | 71 Outperform |
NUMG Technical Analysis
Positive
―
Price Trends
47.69
Positive
48.11
Positive
46.83
Positive
Market Momentum
0.29
Negative
58.85
Neutral
87.47
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 47.77, equal to the 50-day MA of 47.69, and equal to the 200-day MA of 46.83, indicating a bullish trend. The MACD of 0.29 indicates Negative momentum. The RSI at 58.85 is Neutral, neither overbought nor oversold. The STOCH value of 87.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NUMG.
NUMG Peer Comparison
Comparison Results
Performance Comparison
NUMG
Nuveen ESG Mid-Cap Growth ETF
48.65
0.44
0.91%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
―
―
―
RFG
Invesco S&P Midcap 400 Pure Growth ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents